William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories
-
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
-
Viking Therapeutics (VKTX) Announces $350M Proposed Public Offering of Common Stock
-
Viking Therapeutics Announces Proposed Public Offering of Common Stock
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Viking Therapeutics (VKTX) Prices 17.24M Share Offering at $14.50/sh
-
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
-
Viking Therapeutics (VKTX) Announces Proposed Public Offering of Common Stock
-
Viking Therapeutics Announces Proposed Public Offering of Common Stock
-
Viking Therapeutics to Present at William Blair Biotech Focus Conference 2022
-
Viking Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
-
Viking Therapeutics to Participate in Upcoming Investor Conferences
-
Viking Therapeutic (VKTX) Trading Below Cash Initiates a Buyback Program
-
Viking Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
-
Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
-
Viking Therapeutics to Participate in Upcoming Investor Conferences
-
Viking Therapeutics (VKTX) Prices 9.5M Share Offering at $18.50/Sh
-
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
-
Viking Therapeutics (VKTX) Announces Proposed Common Share Offering
-
Viking Therapeutics Announces Proposed Public Offering of Common Stock
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock
-
Viking Therapeutics (VKTX) Prices 7.5M Common Stock Offering at $9/Share
-
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
-
Viking Therapeutics (VKTX) Plans Public Offering of Common Stock
-
Viking Therapeutics Announces Proposed Public Offering of Common Stock
-
Pre-Open Movers 04/30: (STDY) (ANDV) (FDC) Higher; (CTB) (S) (ARNC) Lower (more...)
-
William Blair Starts Viking Therapeutic (VKTX) at Outperform
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock
-
Viking Therapeutics (VKTX) Prices 11M Shares at $5
-
Viking Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock
-
Viking Therapeutics (VKTX) Plans Public Offering of Common Stock
-
Viking Therapeutics Announces Proposed Public Offering of Common Stock
-
Viking Therapeutics Announces Closing of Public Offering of Common Stock
-
Viking Therapeutics (VKTX) Prices 5.13M Share Offering at $2.50/Sh
-
Viking Therapeutics Announces Pricing of $12.8 Million Public Offering of Common Stock
-
Viking Therapeutics (VKTX) Plans Public Offering of Common Stock
-
Viking Therapeutics Announces Proposed Public Offering of Common Stock

